These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38145957)
1. Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma. Zhu JQ; Wu H; Li X; Li MY; Li ZL; Xu XF; Gu LH; Yin DX; Shen F; Huang DS; Yang T Adv Sci (Weinh); 2024 Mar; 11(9):e2305508. PubMed ID: 38145957 [TBL] [Abstract][Full Text] [Related]
2. Injectable adhesive hemostatic gel with tumor acidity neutralizer and neutrophil extracellular traps lyase for enhancing adoptive NK cell therapy prevents post-resection recurrence of hepatocellular carcinoma. Cheng Y; Gong Y; Chen X; Zhang Q; Zhang X; He Y; Pan L; Ni B; Yang F; Xu Y; Zhou L; Yang Y; Chen W Biomaterials; 2022 May; 284():121506. PubMed ID: 35390709 [TBL] [Abstract][Full Text] [Related]
3. In-situ-formed immunotherapeutic and hemostatic dual drug-loaded nanohydrogel for preventing postoperative recurrence of hepatocellular carcinoma. Ke J; Liu Y; Liu F; Cai H; Li X; Zhang Z; Wang N; Shao B; Wang Z; Han M; Ji B J Control Release; 2024 Aug; 372():141-154. PubMed ID: 38885842 [TBL] [Abstract][Full Text] [Related]
4. Photothermal Fibrous Chitosan/Polydopamine Sponge for Intraoperative Hemostasis and Prevention of Tumor Recurrence in Hepatocellular Carcinoma Resection. Mu L; Qi L; Long H; Huang J; Zhong Z; Shi X; Chen C; Ye Q Adv Sci (Weinh); 2024 Jan; 11(3):e2304053. PubMed ID: 38029340 [TBL] [Abstract][Full Text] [Related]
5. Use of asymmetric multilayer polylactide nanofiber mats in controlled release of drugs and prevention of liver cancer recurrence after surgery in mice. Liu S; Wang X; Zhang Z; Zhang Y; Zhou G; Huang Y; Xie Z; Jing X Nanomedicine; 2015 Jul; 11(5):1047-56. PubMed ID: 25804412 [TBL] [Abstract][Full Text] [Related]
6. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Tung-Ping Poon R; Fan ST; Wong J Ann Surg; 2000 Jul; 232(1):10-24. PubMed ID: 10862190 [TBL] [Abstract][Full Text] [Related]
7. Intratumoral Lactate Depletion Based on Injectable Nanoparticles-Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence. Chen Y; Bei J; Chen M; Cai W; Zhou Z; Cai M; Huang W; Lin L; Guo Y; Liu M; Huang X; Xiao Z; Xu Z; Zhu K Adv Healthc Mater; 2024 Mar; 13(6):e2303031. PubMed ID: 37848188 [TBL] [Abstract][Full Text] [Related]
8. Injectable magnetic supramolecular hydrogel with magnetocaloric liquid-conformal property prevents post-operative recurrence in a breast cancer model. Wu H; Song L; Chen L; Zhang W; Chen Y; Zang F; Chen H; Ma M; Gu N; Zhang Y Acta Biomater; 2018 Jul; 74():302-311. PubMed ID: 29729897 [TBL] [Abstract][Full Text] [Related]
9. Injectable Nanocomposite Immune Hydrogel Dressings: Prevention of Tumor Recurrence and Anti-Infection after Melanoma Resection. Zhu W; Zhou Z; Yang M; Chen X; Zhu S; Yu M; Yu Z; Wu W; Liu H Small; 2024 Jul; 20(28):e2309476. PubMed ID: 38348999 [TBL] [Abstract][Full Text] [Related]
10. Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma. Zhang J; Zhou ZG; Huang ZX; Yang KL; Chen JC; Chen JB; Xu L; Chen MS; Zhang YJ Chin J Cancer; 2016 Mar; 35():25. PubMed ID: 26956022 [TBL] [Abstract][Full Text] [Related]
11. pH-responsive nanocomposite hydrogel for simultaneous prevention of postoperative adhesion and tumor recurrence. Zhou J; Wang H; Chen H; Ling Y; Xi Z; Lv M; Chen J Acta Biomater; 2023 Mar; 158():228-238. PubMed ID: 36563777 [TBL] [Abstract][Full Text] [Related]
12. The Importance of the Immunosuppressive Regime on Hepatocellular Carcinoma Recurrence After Liver Transplantation. Yilmaz S; Ince V J Gastrointest Cancer; 2021 Dec; 52(4):1350-1355. PubMed ID: 34611833 [TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of hepatocellular carcinoma and related basic research with special reference to recurrence and metastasis. Tang Z; Zhou X; Lin Z; Yang B; Ma Z; Ye S; Wu Z; Fan J; Liu Y; Liu K; Qin L; Tian J; Sun H; He B; Xia J; Qiu S; Zhou J Chin Med J (Engl); 1999 Oct; 112(10):887-91. PubMed ID: 11717970 [TBL] [Abstract][Full Text] [Related]
14. [Insight and judgment on recurrence of hepatocellular carcinoma after liver transplantation]. Zheng H; Zhang HM; Zheng WP Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):88-92. PubMed ID: 29804372 [TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma. Chen C; Wang Z; Ding Y; Qin Y Front Immunol; 2023; 14():1133308. PubMed ID: 36845131 [TBL] [Abstract][Full Text] [Related]
17. Yan X; Sun T; Song Y; Peng W; Xu Y; Luo G; Li M; Chen S; Fang WW; Dong L; Xuan S; He T; Cao B; Lu Y Nano Lett; 2022 Mar; 22(6):2251-2260. PubMed ID: 35254836 [TBL] [Abstract][Full Text] [Related]
18. [The mechanism and current strategies for preventing the recurrence of hepatocellular carcinoma after liver transplantation]. Wang HQ; Li L; Yang JY Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):93-97. PubMed ID: 29804373 [TBL] [Abstract][Full Text] [Related]
19. Injectable Hydrogels Including Magnetic Nanosheets for Multidisciplinary Treatment of Hepatocellular Carcinoma via Magnetic Hyperthermia. Gong J; Hu J; Yan X; Xiang L; Chen S; Yang H; Chen Z; Hou Q; Song Y; Xu Y; Liu D; Ji C; Qin Q; Sun H; Peng J; Cao B; Lu Y Small; 2024 Jan; 20(3):e2300733. PubMed ID: 37452437 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study. Lygidakis NJ; Pothoulakis J; Konstantinidou AE; Spanos H Anticancer Res; 1995; 15(2):543-50. PubMed ID: 7539237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]